Buy Paclitax : Paclitaxel 100 Mg Injection Online

Description

Description: Paclitax is a medication manufactured by Cipla Ltd. It contains the active substance paclitaxel in each injection. Each package contains vials, each containing 100 milligrams of paclitaxel. Paclitax belongs to a class of medications known as taxanes and is primarily used in the treatment of various types of cancer, including breast cancer, ovarian cancer, lung cancer, and Kaposi sarcoma.

Active Substance: The active substance in Paclitax is paclitaxel. Paclitaxel works by interfering with the microtubule structures in cancer cells, which are essential for cell division and growth. By stabilizing microtubules and preventing their disassembly, paclitaxel disrupts the cell cycle and inhibits cancer cell proliferation, leading to cell death.

Indications: Paclitax is indicated for the treatment of:

• Metastatic breast cancer: It is used in combination with other chemotherapy agents for the treatment of metastatic breast cancer that has not responded to other treatments.
• Ovarian cancer: It is used in combination with other chemotherapy agents for the treatment of advanced ovarian cancer after initial therapy has failed.
• Non-small cell lung cancer (NSCLC): It is used in combination with other chemotherapy agents for the treatment of NSCLC that has not responded to other treatments.
• Kaposi sarcoma: It is used for the treatment of advanced Kaposi sarcoma in patients with HIV infection.

Mechanism of Action:

• Paclitaxel interferes with the normal function of microtubules, which are structures essential for cell division and growth.
• By stabilizing microtubules and preventing their disassembly, paclitaxel disrupts the cell cycle and inhibits cancer cell proliferation.
• This leads to cell cycle arrest and ultimately cell death, reducing tumor growth and spread.

Administration:

• Paclitax injection is administered intravenously (into a vein) by a healthcare professional in a clinical setting, such as a hospital or clinic.
• The dosage and schedule of administration may vary depending on the specific type and stage of cancer being treated, as well as individual patient factors.
• Paclitax injection should be administered under the supervision of a qualified healthcare provider experienced in the use of cytotoxic chemotherapy agents.

Dosage:

• The recommended dosage of Paclitax varies depending on the type of cancer being treated, the patient’s body surface area, and other factors.
• Treatment duration and dosage adjustments may be made based on the patient’s response to treatment and tolerability.

Monitoring:

• Patients receiving Paclitax should be monitored closely by their healthcare provider for any signs of adverse effects or complications, including infusion reactions, allergic reactions, and bone marrow suppression.
• Regular blood tests may be performed to monitor blood cell counts and liver function during treatment.

Side Effects: Common side effects of paclitaxel may include:

• Bone marrow suppression (leading to low blood cell counts)
• Infusion reactions (fever, chills, flushing, chest pain, shortness of breath)
• Peripheral neuropathy (numbness, tingling, or pain in the hands and feet)
• Hair loss (alopecia)
• Nausea and vomiting
• Fatigue
• Muscle or joint pain

Precautions:

• Paclitax should be used with caution in patients with pre-existing liver or kidney disease, as well as in patients with a history of allergic reactions to taxanes or other chemotherapy agents.
• It is important to inform the healthcare provider about all medications, supplements, and herbal products being taken, as paclitaxel may interact with certain medications.
• Women who are pregnant or breastfeeding should not receive Paclitax, as it may cause harm to the fetus or infant.

Consultation with Healthcare Professional:

• The use of Paclitax should be discussed with a qualified healthcare professional, typically an oncologist or hematologist.
• Patients should inform their healthcare provider about their medical history, existing health conditions, and any medications they are taking before starting treatment with paclitaxel.

Paclitax, manufactured by Cipla Ltd, is a medication indicated for the treatment of various types of cancer, including breast cancer, ovarian cancer, lung cancer, and Kaposi sarcoma. Its use involves careful adherence to dosage and instructions for use, as well as regular monitoring by a healthcare provider to assess treatment response and monitor for any adverse effects or complications.